Next-generation Antibody Market 2027 By Therapeutic Area, Technology and Geography | The Insight Partners

Next-generation Antibody Market to 2027 - Global Analysis and Forecasts by Therapeutic Area ( Oncology, Autoimmune or Inflammatory ); Technology ( Antibody-drug conjugates, Bispecific antibodies, Fc engineered antibodies, Antibody fragments and antibody-like proteins, Biosimilar antibody products ), and Geography

Report Code: TIPRE00006412 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION

The next-generation antibody is designed to be more specific and often more potent than traditional monoclonal antibodies. Next-generation antibody strategies are required to engineer a useful therapeutic combining antibody, payload, linker, and conjugation method while ensuring stability, targeted delivery, and limited off-target effects.

MARKET DYNAMICS

The market for next generation antibody market is forecasted to grow during the forecast years due to the huge success of the discovery and development of monoclonal antibodies, rising prevalence of chronic disorders and advent of technology supporting R&D activities are anticipated to drive market. In addition, the innovative R&D approaches incorporated by market players to develop effective and advanced drugs is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Global Next Generation Antibody Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of next generation antibody market with detailed market segmentation by therapeutic area, technology, and geography. The global next generation antibody market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading next generation antibody market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global next generation antibody market is segmented on the basis of therapeutic area and technology. Based on the therapeutic area the market is segmented as oncology and autoimmune or inflammatory. On the basis of technology the next generation antibody is classified as antibody-drug conjugates, bispecific antibodies, FC engineered antibodies, antibody fragments and antibody-like proteins, and biosimilar antibody products.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global next generation antibody market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The next generation antibody market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting next generation antibody market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the next generation antibody market in these regions.

MARKET PLAYERS

The reports cover key developments in the next generation antibody market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from next generation antibody market are anticipated to lucrative growth opportunities in the future with the rising demand for next generation antibody market in the global market. Below mentioned is the list of few companies engaged in the next generation antibody market.

The report also includes the profiles of key next generation antibody market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- F. Hoffmann-La Roche Ltd
- Kyowa Hakko Kirin Co., Ltd.
- Seattle Genetics, Inc.
- ImmunoGen, Inc.
- Bristol-Myers Squibb Company
- Pfizer, Inc.
- Amgen, Inc.
- Biogen
- Bayer AG
- Xencor, Inc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Next-generation Antibody Market - By Therapeutic Area
1.3.2 Next-generation Antibody Market - By Technology
1.3.3 Next-generation Antibody Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NEXT-GENERATION ANTIBODY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NEXT-GENERATION ANTIBODY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NEXT-GENERATION ANTIBODY MARKET - GLOBAL MARKET ANALYSIS
6.1. NEXT-GENERATION ANTIBODY - GLOBAL MARKET OVERVIEW
6.2. NEXT-GENERATION ANTIBODY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. NEXT-GENERATION ANTIBODY MARKET - REVENUE AND FORECASTS TO 2027 - THERAPEUTIC AREA
7.1. OVERVIEW
7.2. THERAPEUTIC AREA MARKET FORECASTS AND ANALYSIS
7.3. ONCOLOGY
7.3.1. Overview
7.3.2. Oncology Market Forecast and Analysis
7.4. AUTOIMMUNE OR INFLAMMATORY
7.4.1. Overview
7.4.2. Autoimmune or Inflammatory Market Forecast and Analysis
8. NEXT-GENERATION ANTIBODY MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. ANTIBODY-DRUG CONJUGATES
8.3.1. Overview
8.3.2. Antibody-drug conjugates Market Forecast and Analysis
8.4. BISPECIFIC ANTIBODIES
8.4.1. Overview
8.4.2. Bispecific antibodies Market Forecast and Analysis
8.5. FC ENGINEERED ANTIBODIES
8.5.1. Overview
8.5.2. Fc engineered antibodies Market Forecast and Analysis
8.6. ANTIBODY FRAGMENTS AND ANTIBODY-LIKE PROTEINS
8.6.1. Overview
8.6.2. Antibody fragments and antibody-like proteins Market Forecast and Analysis
8.7. BIOSIMILAR ANTIBODY PRODUCTS
8.7.1. Overview
8.7.2. Biosimilar antibody products Market Forecast and Analysis
9. NEXT-GENERATION ANTIBODY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Next-generation Antibody Market Overview
9.1.2 North America Next-generation Antibody Market Forecasts and Analysis
9.1.3 North America Next-generation Antibody Market Forecasts and Analysis - By Therapeutic Area
9.1.4 North America Next-generation Antibody Market Forecasts and Analysis - By Technology
9.1.5 North America Next-generation Antibody Market Forecasts and Analysis - By Countries
9.1.5.1 United States Next-generation Antibody Market
9.1.5.1.1 United States Next-generation Antibody Market by Therapeutic Area
9.1.5.1.2 United States Next-generation Antibody Market by Technology
9.1.5.2 Canada Next-generation Antibody Market
9.1.5.2.1 Canada Next-generation Antibody Market by Therapeutic Area
9.1.5.2.2 Canada Next-generation Antibody Market by Technology
9.1.5.3 Mexico Next-generation Antibody Market
9.1.5.3.1 Mexico Next-generation Antibody Market by Therapeutic Area
9.1.5.3.2 Mexico Next-generation Antibody Market by Technology
9.2. EUROPE
9.2.1 Europe Next-generation Antibody Market Overview
9.2.2 Europe Next-generation Antibody Market Forecasts and Analysis
9.2.3 Europe Next-generation Antibody Market Forecasts and Analysis - By Therapeutic Area
9.2.4 Europe Next-generation Antibody Market Forecasts and Analysis - By Technology
9.2.5 Europe Next-generation Antibody Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Next-generation Antibody Market
9.2.5.1.1 Germany Next-generation Antibody Market by Therapeutic Area
9.2.5.1.2 Germany Next-generation Antibody Market by Technology
9.2.5.2 France Next-generation Antibody Market
9.2.5.2.1 France Next-generation Antibody Market by Therapeutic Area
9.2.5.2.2 France Next-generation Antibody Market by Technology
9.2.5.3 Italy Next-generation Antibody Market
9.2.5.3.1 Italy Next-generation Antibody Market by Therapeutic Area
9.2.5.3.2 Italy Next-generation Antibody Market by Technology
9.2.5.4 Spain Next-generation Antibody Market
9.2.5.4.1 Spain Next-generation Antibody Market by Therapeutic Area
9.2.5.4.2 Spain Next-generation Antibody Market by Technology
9.2.5.5 United Kingdom Next-generation Antibody Market
9.2.5.5.1 United Kingdom Next-generation Antibody Market by Therapeutic Area
9.2.5.5.2 United Kingdom Next-generation Antibody Market by Technology
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Next-generation Antibody Market Overview
9.3.2 Asia-Pacific Next-generation Antibody Market Forecasts and Analysis
9.3.3 Asia-Pacific Next-generation Antibody Market Forecasts and Analysis - By Therapeutic Area
9.3.4 Asia-Pacific Next-generation Antibody Market Forecasts and Analysis - By Technology
9.3.5 Asia-Pacific Next-generation Antibody Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Next-generation Antibody Market
9.3.5.1.1 Australia Next-generation Antibody Market by Therapeutic Area
9.3.5.1.2 Australia Next-generation Antibody Market by Technology
9.3.5.2 China Next-generation Antibody Market
9.3.5.2.1 China Next-generation Antibody Market by Therapeutic Area
9.3.5.2.2 China Next-generation Antibody Market by Technology
9.3.5.3 India Next-generation Antibody Market
9.3.5.3.1 India Next-generation Antibody Market by Therapeutic Area
9.3.5.3.2 India Next-generation Antibody Market by Technology
9.3.5.4 Japan Next-generation Antibody Market
9.3.5.4.1 Japan Next-generation Antibody Market by Therapeutic Area
9.3.5.4.2 Japan Next-generation Antibody Market by Technology
9.3.5.5 South Korea Next-generation Antibody Market
9.3.5.5.1 South Korea Next-generation Antibody Market by Therapeutic Area
9.3.5.5.2 South Korea Next-generation Antibody Market by Technology
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Next-generation Antibody Market Overview
9.4.2 Middle East and Africa Next-generation Antibody Market Forecasts and Analysis
9.4.3 Middle East and Africa Next-generation Antibody Market Forecasts and Analysis - By Therapeutic Area
9.4.4 Middle East and Africa Next-generation Antibody Market Forecasts and Analysis - By Technology
9.4.5 Middle East and Africa Next-generation Antibody Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Next-generation Antibody Market
9.4.5.1.1 South Africa Next-generation Antibody Market by Therapeutic Area
9.4.5.1.2 South Africa Next-generation Antibody Market by Technology
9.4.5.2 Saudi Arabia Next-generation Antibody Market
9.4.5.2.1 Saudi Arabia Next-generation Antibody Market by Therapeutic Area
9.4.5.2.2 Saudi Arabia Next-generation Antibody Market by Technology
9.4.5.3 U.A.E Next-generation Antibody Market
9.4.5.3.1 U.A.E Next-generation Antibody Market by Therapeutic Area
9.4.5.3.2 U.A.E Next-generation Antibody Market by Technology
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Next-generation Antibody Market Overview
9.5.2 South and Central America Next-generation Antibody Market Forecasts and Analysis
9.5.3 South and Central America Next-generation Antibody Market Forecasts and Analysis - By Therapeutic Area
9.5.4 South and Central America Next-generation Antibody Market Forecasts and Analysis - By Technology
9.5.5 South and Central America Next-generation Antibody Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Next-generation Antibody Market
9.5.5.1.1 Brazil Next-generation Antibody Market by Therapeutic Area
9.5.5.1.2 Brazil Next-generation Antibody Market by Technology
9.5.5.2 Argentina Next-generation Antibody Market
9.5.5.2.1 Argentina Next-generation Antibody Market by Therapeutic Area
9.5.5.2.2 Argentina Next-generation Antibody Market by Technology
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. NEXT-GENERATION ANTIBODY MARKET, KEY COMPANY PROFILES
11.1. F. HOFFMANN-LA ROCHE LTD
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. KYOWA HAKKO KIRIN CO., LTD.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. SEATTLE GENETICS, INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. IMMUNOGEN, INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BRISTOL-MYERS SQUIBB COMPANY
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. PFIZER, INC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. AMGEN, INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. BIOGEN
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. BAYER AG
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. XENCOR, INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. F. Hoffmann-La Roche Ltd
2. Kyowa Hakko Kirin Co., Ltd.
3. Seattle Genetics, Inc.
4. ImmunoGen, Inc.
5. Bristol-Myers Squibb Company
6. Pfizer, Inc.
7. Amgen, Inc.
8. Biogen
9. Bayer AG
10. Xencor, Inc.